Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Oct 05, 2023
Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination
Read more
Scientific Article
/ Nov 30, 2023
Webinar - Nasal powder delivery: Process, formulation and analytical characterization
Read more
Scientific Article
Scientific Article